STANDARD BIOTOOLS INC. (LAB) › RevenueSTANDARD BIOTOOLS INC. (LAB) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $104.45M2017: $101.94M2018: $112.96M2019: $117.24M2020: $138.14M2021: $130.58M2022: $97.95M2023: $106.34M2024: $91.01M2025: $85.33M$85.33M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$85.33M-6.2%2024$91.01M-14.4%2023$106.34M+8.6%2022$97.95M-25.0%2021$130.58M-5.5%2020$138.14M+17.8%2019$117.24M+3.8%2018$112.96M+10.8%2017$101.94M-2.4%2016$104.45M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share